Use of DALYs in economic analyses on interventions for infectious diseases: A systematic review

A.J.J.M. Oostvogels, G.A. De Wit, B. Jahn, A. Cassini, E. Colzani, C. De Waure, M.E.E. Kretzschmar, U. Siebert, N. Mühlberger, M.-J.J. Mangen

Research output: Contribution to JournalReview articleAcademicpeer-review


Copyright © Cambridge University Press 2014.A systematic literature review was performed on full economic evaluations of infectious disease interventions using disability-adjusted life years (DALY) as outcome measure. The search was limited to the period between 1994 and September 2011 and conducted in Medline, SciSearch and EMBASE databases. We included 154 studies, mostly targeting HIV/AIDS and malaria with most conducted for African countries (40%) and <10% in high-income countries. Third-payer perspective was applied in 29% of the studies, 25% used the societal perspective and 12% used both. Only 16% of the studies took indirect effects (i.e. herd immunity) of interventions into account. Intervention, direct healthcare and indirect non-healthcare costs were taken into account in respectively 100%, 81% and 36% of the studies. The majority of the studies followed the Global Burden of Disease method for DALY estimations, but most studies deviated from WHO cost-effectiveness guidelines. Better adherence to freely accessible guidelines will improve generalizability between full economic evaluations.
Original languageEnglish
Pages (from-to)1791-1802
JournalEpidemiology and Infection
Issue number9
Publication statusPublished - 1 Jul 2015
Externally publishedYes


Dive into the research topics of 'Use of DALYs in economic analyses on interventions for infectious diseases: A systematic review'. Together they form a unique fingerprint.

Cite this